-Down to Earth India’s GDP for health is less than 1.5 per cent and is one of the lowest in the world Health infrastructure, especially in the rural areas, is going to be one of the challenging tasks ahead for the new government. In its last tenure, it brought the Ayushman Bharat scheme — the government run health insurance programme — which was seen as a major health policy intervention. However, according...
More »SEARCH RESULT
Total Matching Records found : 137
Many essential drugs priced much higher than manufacturing cost: WHO -Sushmi Dey
-The Times of India NEW DELHI: Around 40% of the essential medicines in India with lowest MRP are priced significantly higher than estimated production costs, an assessment by the World Health Organisation (WHO) shows highlighting the “exorbitant” profiteering by pharmaceutical companies and the scope for lowering prices of drugs. While innovative and newer drugs for cancer, hepatitis C and rare diseases are out of reach of many due to their unaffordable prices,...
More »Prices of essential medicines, stents to go up by over 4% -Rupali Mukherjee
-The Times of India MUMBAI: Prices of essential medicines, including painkillers, anti-infectives, supplements and antibiotics, will go up by over 4%, after the government gave its nod to the increase, in line with the annual Wholesale Price Index (WPI). Hike in prices of cardiac stents have also been allowed on the basis of WPI at 4.26% for calendar year 2018. The revision in prices of both stents and medicines will come...
More »Holes in cancer drug price cap -GS Mudur
-The Telegraph Call to govt to adopt 'cost-based' control The 30 per cent cap on profit margins imposed by India’s drug pricing authority on 42 anti-cancer drugs will have a limited impact on patients’ expenses because many of these medicines’ prices remain “prohibitive”, a network of patients’ rights groups said on Saturday. The All India Drug Action Network (Aidan) said the National Pharmaceutical Pricing Authority’s cap on profit margins in effect “legitimises” the...
More »Govt forms Niti-led panel to monitor pricing of drugs -Rupali Mukherjee
-The Hindu Business Line MUMBAI: The government on Monday constituted a standing committee headed by Niti Aayog to oversee the drug pricing regime, a move which could clip the powers of drug pricing regulator, National Pharmaceutical Pricing Authority (NPPA). The Standing Committee on Affordable Medicines and Health Products will be headed by NITI Aayog member (health), and includes chief economic adviser, besides secretary department of health research, director general of health...
More »
